BeOne Medicines ONC
NASDAQ ONC
$358.85 -3.83 (-1.06%)
As of: Sep 4, 2026 · 2:24 PM EDT

BeOne Medicines (ONC) Gross Margin (QoQ) (2017 - 2026)

Analysis

BeOne Medicines (ONC) Gross Margin (QoQ) (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
10 Incyte 25.61 Bn 21.07 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 81.00
Mar 31, 2026 -154.00
Dec 31, 2025 441.00
Sep 30, 2025 -140.00
Jun 30, 2025 225.00
Mar 31, 2025 -53.00
Dec 31, 2024 278.00
Sep 30, 2024 -215.00
Jun 30, 2024 176.00
Mar 31, 2024 6.00
Dec 31, 2023 -436.00
Sep 30, 2023 380.00
Jun 30, 2023 214.00
Mar 31, 2023 108.00
Dec 31, 2022 40.00
Sep 30, 2022 109.00
Jun 30, 2022 44.00
Mar 31, 2022 141.00
Dec 31, 2021 28.00
Sep 30, 2021 121.00